United Capital Financial Advisers, LLC Novo Cure LTD Transaction History

United Capital Financial Advisers, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $455,921 - $608,346	7,126 Added 89.1%	15,124 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $5,031 - $6,628	-74 Reduced 0.92%	7,998 $608,000
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $9,735 - $15,462	172 Added 2.18%	8,072 $561,000
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $25,563 - $35,921	425 Added 5.69%	7,900 $655,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $580 - $972	-5 Reduced 0.07%	7,475 $868,000
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $521 - $902	4 Added 0.05%	7,480 $1.66 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $1,365 - $2,091	-11 Reduced 0.15%	7,476 $988,000
Q4 2020 Feb 17, 2021	BUY	$112.16 - $174.14 $2,018 - $3,134	18 Added 0.24%	7,487 $1.3 Million
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $34,830 - $66,786	-600 Reduced 7.44%	7,469 $831,000
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $34,320 - $44,646	600 Added 8.03%	8,069 $478,000
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $627 - $1,053	11 Added 0.15%	7,469 $503,000
Q3 2019 Feb 14, 2020	BUY	$61.86 - $97.8 $461,351 - $729,392	7,458 New	7,458 $558,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $457,702 - $723,622	-7,399 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $3,673 - $5,501	87 Added 1.19%	7,399 $468,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $36,273 - $66,471	-1,263 Reduced 14.73%	7,312 $245,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $8,416 - $13,781	263 Added 3.16%	8,575 $449,000
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $164,993 - $265,984	8,312 New	8,312 $260,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.